The pretreatment of cancer cells with NO donors has the potential to enhance the activity of transcription factors like activator protein-1 (AP-1) and facilitate the translocation of NF-κB into the nucleus, leading to the increase of the transcription of iNOS [159]. Here, NFKB1 is linked to cancer.